Evidence map›Paper›PMID 26646856›Full record

ArticlePLoS pathogens2015

Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly.

Kai Xu, Yee-Peng Chan, Birgit Bradel-Tretheway, Zeynep Akyol-Ataman, Yongqun Zhu, Somnath Dutta, Lianying Yan, YanRu Feng, Lin-Fa Wang, Georgios Skiniotis and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Functional and antigenic constraints on the Nipah virus fusion protein.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. FromImmune network · 2026
    Review
  7. Functional and antigenic constraints on the Nipah virus fusion protein.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Nipah virus: pathogenesis, genome, diagnosis, and treatment.Applied microbiology and biotechnology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 4 countries.

Kai XuStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Yee-Peng ChanDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America.
Birgit Bradel-TrethewayPaul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, United States of America.
Zeynep Akyol-AtamanDepartment of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States of America.
Yongqun ZhuLife Sciences Institute and Innovation Center for Cell Biology, Zhejiang University, Hangzhou, Zhejiang, China.
Somnath DuttaLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Lianying YanDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America.
YanRu FengDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America.
Lin-Fa WangCSIRO Animal, Food and Health Sciences, Australian Animal Health Laboratory, Geelong, Victoria, Australia.
Georgios SkiniotisLife Sciences Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
Benhur LeeDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Z Hong ZhouDepartment of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States of America.
Christopher C BroderDepartment of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America.
Hector C AguilarPaul G. Allen School for Global Animal Health, Washington State University, Pullman, Washington, United States of America.
Dimitar B NikolovStructural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America.
Uniformed Services University of the Health Sciences · USMemorial Sloan Kettering Cancer Center · USUniversity of California, Los Angeles · USWashington State University · USCommonwealth Scientific and Industrial Research Organisation · AUIcahn School of Medicine at Mount Sinai · USMichigan United · USUniversity of Michigan · USZhejiang University · CN

Funding

Vaccines and Therapeutics for Nipah and Hendra virusU01AI077995 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2008 to 2012
$5.5M
Mechanisms of Nipah virus fusion and entryR01AI109022 · NIAID · WASHINGTON STATE UNIVERSITY · PI AGUILAR-CARRENO, HECTOR · 2014 to 2024
$4.3M
Nipah Virus and Hendra Virus Entry and Virion AssemblyR01AI054715 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2006 to 2016
$3.1M
SYNUCLEIN AND NIGRAL DOPAMINERGIC NEURON DEGENERATIONR01NS038586 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PRZEDBORSKI, SERGE E · 1999 to 2003
$1.3M
Dissecting the early steps of the Nipah virus fusion cascadeR21AI094329 · NIAID · WASHINGTON STATE UNIVERSITY · PI AGUILAR-CARRENO, HECTOR · 2012 to 2013
$415k
NIAID NIH HHS AI054715NIAID NIH HHS AI077995NIAID NIH HHS R01 AI054715NIAID NIH HHS R01 AI109022NIAID NIH HHS R21 AI094329NIAID NIH HHS U01 AI077995NINDS NIH HHS NS38586NINDS NIH HHS R01 NS038586
6 · The paper itself

Abstract

Nipah virus (NiV) is a paramyxovirus that infects host cells through the coordinated efforts of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the fusion (F) glycoprotein to execute membrane fusion. Here we report the first crystal structure of the pre-fusion form of the NiV-F glycoprotein ectodomain. Interestingly this structure also revealed a hexamer-of-trimers encircling a central axis. Electron tomography of Nipah virus-like particles supported the hexameric pre-fusion model, and biochemical analyses supported the hexamer-of-trimers F assembly in solution. Importantly, structure-assisted site-directed mutagenesis of the interfaces between F trimers highlighted the functional relevance of the hexameric assembly. Shown here, in both cell-cell fusion and virus-cell fusion systems, our results suggested that this hexamer-of-trimers assembly was important during fusion pore formation. We propose that this assembly would stabilize the pre-fusion F conformation prior to cell attachment and facilitate the coordinated transition to a post-fusion conformation of all six F trimers upon triggering of a single trimer. Together, our data reveal a novel and functional pre-fusion architecture of a paramyxoviral fusion glycoprotein.

Indexed as

Virus InternalizationCrystallography, X-RayElectrophoresis, Polyacrylamide GelHEK293 CellsHenipavirus InfectionsHumansMutagenesis, Site-DirectedNipah VirusProtein ConformationViral Envelope ProteinsF protein, Nipah virusViral Envelope Proteins

Identifiers

PMID26646856
PMCPMC4672880
OpenAlexW2194722774

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.